Ryan Spencer's Net Worth
$3.99 Million
Who is Ryan Spencer?
Ryan Spencer has an estimated net worth of $3.99 Million. This is based on reported shares across multiple companies, which include DYNAVAX TECHNOLOGIES CORP, and Cidara Therapeutics, Inc..
SEC CIK
Ryan Spencer's CIK is 0001777938
Past Insider Trading and Trends
2022 was Ryan Spencer's most active year for acquiring shares with 11 total transactions. Ryan Spencer's most active month to acquire stocks was the month of January. 2022 was Ryan Spencer's most active year for disposing of shares, totalling 6 transactions. Ryan Spencer's most active month to dispose stocks was the month of January. 2023 saw Ryan Spencer paying a total of $17,377.78 for 342,258 shares, this is the most they've acquired in one year. In 2022 Ryan Spencer cashed out on 148,612 shares for a total of $1,130,322.37, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
DYNAVAX TECHNOLOGIES CORP (DVAX) Snapshot price: $10.7
CEO and Director
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +0.20% | 402 |
$9.45 | $3,798.90 | 201.03K |
Feb 15
| |||
Form 4
| +4.78% | 9.15K |
$12.82 | -$149,788.88 | 200.63K |
Feb 10 - Feb 12
| |||
Form 4
| +7.06% | 12.62K |
$12.79 | -$219,079.91 | 191.48K |
Feb 4 - Feb 5
| |||
Form 4
| +20.61% | 30.49K |
$10.36 | -$310,592.80 | 178.46K |
Feb 27
| |||
Form 4
| +2.39% | 3.45K |
$10.00 | $34,541.50 | 147.97K |
Aug 15 - Feb 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 9
| |||
Form 4
| +11.36% | 14.74K |
$16.92 | -$252,399.16 | 144.51K |
Aug 8 - Aug 9
| |||
Form 4
| -19.32% | -31.07K |
$10.43 | -$877,923.21 | 129.77K |
Feb 15 - Mar 3
| |||
Form 4
| +131.02% | 91.22K |
$3.39 | $6,674.91 | 160.84K |
Aug 13 - Feb 10
| |||
Form 4
| +19.91% | 11.56K |
$6.50 | -$103,593.60 | 69.62K |
Feb 22
| |||
Form 4
| +2.68% | 1.52K |
$3.39 | $5,146.02 | 58.06K |
Aug 14 - Feb 4
| |||
Form 4
| +92.76% | 27.21K |
—
|
—
| 56.54K |
Feb 22
| |||
Form 4
| +5.88% | 1.56K |
—
|
—
| 28.12K |
Feb 5 - Feb 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
| +23.54% | 4.88K |
—
|
—
| 25.58K |
Jun 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Cidara Therapeutics, Inc. (CDTX) Snapshot price: $13
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||